CAR-T treatment can cause toxicities such cytokine release syndrome (CRS) and neurotoxicity due to increased immunological activation and inflammatory cytokines such as IL-6 and IL-1β from monocytes/macrophages. The gene discussed is IL1B; the disease is congenital rubella syndrome.